Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on photodynamic therapy.

C D Regillo1

  • 1Wills Eye Hospital, Philadelphia, Pennsylvania 19107, USA.

Current Opinion in Ophthalmology
|September 8, 2000
PubMed
Summary
This summary is machine-generated.

Photodynamic therapy offers a selective treatment for choroidal neovascularization, preserving vision. This approach significantly reduces visual loss risk in age-related macular degeneration patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-initiated second medical opinions: their necessity and economic cost.

Retina (Philadelphia, Pa.)·2002
Same author

Hypopyon uveitis in immunocompetent patients treated for Mycobacterium avium complex pulmonary infection with rifabutin.

Retina (Philadelphia, Pa.)·2001
Same author

Treatment of subretinal hemorrhages with tissue plasminogen activator.

Current opinion in ophthalmology·2001
Same author

Bungee cord-associated ocular trauma.

Ophthalmology·2001
Same author

Diabetes and retinopathy.

Ophthalmology·2000
Same author

Juxtapapillary capillary hemangiomas. Clinical features and visual acuity outcomes.

Ophthalmology·2000
Same journal

Laser vision correction (LASIK, PRK, SMILE) with simultaneous accelerated corneal crosslinking.

Current opinion in ophthalmology·2026
Same journal

Traumatic macular hole: observe, operate, or other options.

Current opinion in ophthalmology·2026
Same journal

The evolving role of artificial intelligence in ophthalmology: basic science, translation, and clinical integration.

Current opinion in ophthalmology·2026
Same journal

Editorial: reducing risk for refractive surgery.

Current opinion in ophthalmology·2026
Same journal

Updates on Refractive Surgery: Benefits, Risks, and Costs of Modern Treatment Options.

Current opinion in ophthalmology·2026
Same journal

Corneal Allogeneic Intrastromal Ring Segments for keratoconus - recent evidence and the move to customized and custom shaped CAIRS.

Current opinion in ophthalmology·2026
See all related articles

Area of Science:

  • Ophthalmology
  • Medical Treatments
  • Regenerative Medicine

Background:

  • Choroidal neovascularization (CNV) is a leading cause of vision loss.
  • Traditional treatments like laser photocoagulation can cause collateral damage.
  • Subfoveal CNV poses a particular challenge due to its proximity to the macula.

Purpose of the Study:

  • To evaluate the efficacy and safety of photodynamic therapy (PDT) for treating CNV.
  • To assess PDT's potential to preserve visual function compared to existing methods.
  • To highlight the impact of PDT on age-related macular degeneration (AMD).

Main Methods:

  • Investigating various photosensitive dyes for PDT.
  • Conducting formal clinical trials to assess treatment outcomes.

Related Experiment Videos

  • Monitoring visual function and tissue damage post-treatment.

    • Main Results:

    • PDT demonstrates high selectivity in closing CNV.
    • Minimal to no detectable damage to surrounding ocular tissues observed.
    • Significant reduction in the risk of visual loss in patients with subfoveal CNV from AMD.

    Conclusions:

    • PDT is a promising, less invasive treatment for CNV.
    • It effectively preserves central visual function, especially in subfoveal cases.
    • PDT is poised to significantly benefit public health, particularly in regions with high AMD prevalence.